NO20072755L - Fremgangsmate for fremstilling av 4-(6-klor-2-metylendioksyanilino)-7-2-(4-metylpiperazin-1-yl)etoksy]-5-tetrahydropyran-4-yloksykinazolin, deres mellomprodukter og krystallinske salter derav - Google Patents
Fremgangsmate for fremstilling av 4-(6-klor-2-metylendioksyanilino)-7-2-(4-metylpiperazin-1-yl)etoksy]-5-tetrahydropyran-4-yloksykinazolin, deres mellomprodukter og krystallinske salter deravInfo
- Publication number
- NO20072755L NO20072755L NO20072755A NO20072755A NO20072755L NO 20072755 L NO20072755 L NO 20072755L NO 20072755 A NO20072755 A NO 20072755A NO 20072755 A NO20072755 A NO 20072755A NO 20072755 L NO20072755 L NO 20072755L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- intermediates
- yloxyquinazoline
- methylenedioxyanilino
- methylpiperazin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0427697.8A GB0427697D0 (en) | 2004-12-17 | 2004-12-17 | Chemical process |
| PCT/GB2005/004807 WO2006064217A2 (en) | 2004-12-17 | 2005-12-14 | PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072755L true NO20072755L (no) | 2007-07-02 |
Family
ID=34090249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072755A NO20072755L (no) | 2004-12-17 | 2007-05-30 | Fremgangsmate for fremstilling av 4-(6-klor-2-metylendioksyanilino)-7-2-(4-metylpiperazin-1-yl)etoksy]-5-tetrahydropyran-4-yloksykinazolin, deres mellomprodukter og krystallinske salter derav |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8304417B2 (ko) |
| EP (1) | EP1871769B1 (ko) |
| JP (2) | JP5161584B2 (ko) |
| KR (6) | KR20080094847A (ko) |
| CN (1) | CN101115744B (ko) |
| AU (2) | AU2005315458B2 (ko) |
| BR (1) | BRPI0519085A2 (ko) |
| CA (2) | CA2590735C (ko) |
| ES (1) | ES2622480T3 (ko) |
| GB (1) | GB0427697D0 (ko) |
| IL (1) | IL183525A0 (ko) |
| MX (1) | MX2007007210A (ko) |
| NO (1) | NO20072755L (ko) |
| NZ (1) | NZ555468A (ko) |
| WO (1) | WO2006064217A2 (ko) |
| ZA (1) | ZA200704532B (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0412074D0 (en) * | 2004-05-29 | 2004-06-30 | Astrazeneca Ab | Combination product |
| WO2009068906A2 (en) * | 2007-11-26 | 2009-06-04 | Astrazeneca Ab | Combinations comprising zd4054 and a src family kinase inhibitor 172 |
| CN103275072B (zh) * | 2013-05-22 | 2016-01-20 | 苏州明锐医药科技有限公司 | 塞卡替尼的制备方法 |
| US10660957B2 (en) * | 2013-06-13 | 2020-05-26 | Yale University | Compositions and methods for treating an Aβ-modulated disease or disorder or improving cognition in a subject |
| US11241434B2 (en) | 2013-06-13 | 2022-02-08 | Yale Uninversity | Compositions and methods for improving cognition in a subject |
| US10369152B2 (en) | 2015-02-13 | 2019-08-06 | The Brigham And Women's Hospital, Inc. | Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue |
| FI3930715T3 (fi) | 2019-02-27 | 2024-08-05 | Astrazeneca Ab | Sarakatinibi käytettäväksi idiopaattisen keuhkofibroosin hoidossa |
| CN116332789A (zh) * | 2023-03-10 | 2023-06-27 | 上海康鹏科技股份有限公司 | 一种4-氨基-2-氟苯甲酰胺的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| SK2142003A3 (en) | 2000-08-21 | 2003-07-01 | Astrazeneca Ab | Quinazoline derivatives, process for their preparation, pharmaceutical composition comprising same and their use |
| ES2312557T3 (es) | 2001-04-19 | 2009-03-01 | Astrazeneca Ab | Derivados de quinazolina. |
| WO2004041829A1 (en) | 2002-11-04 | 2004-05-21 | Astrazeneca Ab | Quinazoline derivatives as src tyrosine kinase inhibitors |
| GB0226434D0 (en) * | 2002-11-13 | 2002-12-18 | Astrazeneca Ab | Combination product |
| GB0307333D0 (en) | 2003-03-29 | 2003-05-07 | Astrazeneca Ab | Therapeutic agent |
| GB0309850D0 (en) | 2003-04-30 | 2003-06-04 | Astrazeneca Ab | Quinazoline derivatives |
| GB0310401D0 (en) * | 2003-05-07 | 2003-06-11 | Astrazeneca Ab | Therapeutic agent |
-
2004
- 2004-12-17 GB GBGB0427697.8A patent/GB0427697D0/en not_active Ceased
-
2005
- 2005-12-14 JP JP2007546172A patent/JP5161584B2/ja active Active
- 2005-12-14 WO PCT/GB2005/004807 patent/WO2006064217A2/en active Application Filing
- 2005-12-14 KR KR1020087023971A patent/KR20080094847A/ko not_active Application Discontinuation
- 2005-12-14 CA CA002590735A patent/CA2590735C/en active Active
- 2005-12-14 KR KR1020077015972A patent/KR20070090004A/ko active Search and Examination
- 2005-12-14 KR KR1020087023973A patent/KR20080094849A/ko not_active Application Discontinuation
- 2005-12-14 KR KR1020117022793A patent/KR20110114727A/ko not_active Application Discontinuation
- 2005-12-14 NZ NZ555468A patent/NZ555468A/en not_active IP Right Cessation
- 2005-12-14 BR BRPI0519085-1A patent/BRPI0519085A2/pt not_active IP Right Cessation
- 2005-12-14 AU AU2005315458A patent/AU2005315458B2/en active Active
- 2005-12-14 KR KR1020087023972A patent/KR20080094848A/ko not_active Application Discontinuation
- 2005-12-14 EP EP05818127.2A patent/EP1871769B1/en active Active
- 2005-12-14 CA CA002675642A patent/CA2675642A1/en not_active Abandoned
- 2005-12-14 CN CN2005800476248A patent/CN101115744B/zh active Active
- 2005-12-14 KR KR1020087023969A patent/KR20080094846A/ko not_active Application Discontinuation
- 2005-12-14 ES ES05818127.2T patent/ES2622480T3/es active Active
- 2005-12-14 US US11/793,064 patent/US8304417B2/en active Active
- 2005-12-14 MX MX2007007210A patent/MX2007007210A/es not_active Application Discontinuation
-
2007
- 2007-05-29 IL IL183525A patent/IL183525A0/en unknown
- 2007-05-30 NO NO20072755A patent/NO20072755L/no not_active Application Discontinuation
- 2007-05-31 ZA ZA200704532A patent/ZA200704532B/en unknown
-
2008
- 2008-12-15 JP JP2008318186A patent/JP2009143920A/ja active Pending
-
2009
- 2009-02-18 AU AU2009200622A patent/AU2009200622A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1871769A2 (en) | 2008-01-02 |
| IL183525A0 (en) | 2007-09-20 |
| JP5161584B2 (ja) | 2013-03-13 |
| CN101115744B (zh) | 2012-02-01 |
| KR20080094846A (ko) | 2008-10-24 |
| WO2006064217A2 (en) | 2006-06-22 |
| WO2006064217A8 (en) | 2007-07-05 |
| AU2005315458A1 (en) | 2006-06-22 |
| BRPI0519085A2 (pt) | 2008-12-23 |
| AU2005315458B2 (en) | 2009-03-12 |
| AU2009200622A1 (en) | 2009-03-12 |
| NZ555468A (en) | 2010-12-24 |
| CN101115744A (zh) | 2008-01-30 |
| CA2675642A1 (en) | 2006-06-22 |
| JP2008524183A (ja) | 2008-07-10 |
| CA2590735A1 (en) | 2006-06-22 |
| KR20080094848A (ko) | 2008-10-24 |
| KR20080094849A (ko) | 2008-10-24 |
| US20090099196A1 (en) | 2009-04-16 |
| US8304417B2 (en) | 2012-11-06 |
| ZA200704532B (en) | 2008-07-30 |
| EP1871769B1 (en) | 2017-02-22 |
| ES2622480T3 (es) | 2017-07-06 |
| KR20070090004A (ko) | 2007-09-04 |
| KR20080094847A (ko) | 2008-10-24 |
| JP2009143920A (ja) | 2009-07-02 |
| MX2007007210A (es) | 2007-11-07 |
| WO2006064217A3 (en) | 2006-12-21 |
| GB0427697D0 (en) | 2005-01-19 |
| KR20110114727A (ko) | 2011-10-19 |
| CA2590735C (en) | 2009-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072755L (no) | Fremgangsmate for fremstilling av 4-(6-klor-2-metylendioksyanilino)-7-2-(4-metylpiperazin-1-yl)etoksy]-5-tetrahydropyran-4-yloksykinazolin, deres mellomprodukter og krystallinske salter derav | |
| NO20063597L (no) | Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| NO20083542L (no) | Nye kumarinderivater med antitumoraktivitet | |
| NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
| NO20071593L (no) | Pyrimidinderivater | |
| NO20063468L (no) | Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister | |
| NO20063470L (no) | Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister | |
| NO20063469L (no) | Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister | |
| NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
| NO20051826L (no) | Heterosyklisk substituerte piperaziner for behandling av schizofreni | |
| NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
| NO20055219L (no) | Nye forbindelser | |
| NO20073572L (no) | Nye forbindelser | |
| NO20084363L (no) | 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister | |
| NO20075059L (no) | Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase | |
| NO20075113L (no) | Proteinkinaseinhibitorer | |
| NO20073730L (no) | Amidderivater | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
| NO20085212L (no) | Nye pyridinanaloger | |
| NO20092689L (no) | Quinuclidinolderivater som muskarin reseptorantagonister | |
| PE20070081A1 (es) | Derivados de 2,6-quinolinilo y preparaciones que los comprenden | |
| NO20076695L (no) | Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser | |
| SG171681A1 (en) | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor | |
| NO20074303L (no) | 7-{4-[2-(2,6-diklor-4-metylfenoksy)etoksy]fenyl}-3,9-diazabisyklo-[3.3.1]non-6-en-6-karboksylsyresyklopropyl-(2,3-dimetylbenzyl)amid som renininhibitor til behandling av hypertensjon | |
| IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |